Oncology 2020: a drug development and approval paradigm

被引：21
作者：
Dhingra, K. [1 ]
机构：
[1] KAPital Consulting LLC, Sparta, NJ 07871 USA
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷 / 11期
关键词：
D O I：
10.1093/annonc/mdv353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2347 / 2350
页数：4
相关论文
共 50 条
  • [31] Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
    Al-Huniti, Nidal
    Feng, Yan
    Yu, Jingyu Jerry
    Lu, Zheng
    Nagase, Mario
    Zhou, Diansong
    Sheng, Jennifer
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (08): : 419 - 427
  • [32] Potential conflict between fundamental ethical principles and requirements of the oncology drug approval process - Ethical conflict in drug approval
    Markman, M
    DeMarco, J
    CANCER, 2003, 98 (02) : 215 - 218
  • [33] Oncology drug clinical development and approval in Japan: the role of the pharmaceuticals and medical devices evaluation center (PMDEC)
    Fujiwara, Y
    Kobayashi, K
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 42 (02) : 145 - 155
  • [34] Utility of biomarkers in drug development and approval
    Gueyffier, F
    Dib, M
    Boissel, JP
    THERAPIE, 2001, 56 (04): : 355 - 361
  • [35] Nonimaging detectors in drug development and approval
    Wagner, HN
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, : 125S - 126S
  • [36] Expedited programs for drug development and approval
    Pariser, Anne R.
    Robb, Melissa
    Sherman, Rachel E.
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (07): : 507 - 510
  • [37] Drug development, drug repositioning in oncology
    Ozunal, Z. G.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S105 - S105
  • [38] Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
    Jan, Nusrat
    Sofi, Shazia
    Qayoom, Hina
    Shabir, Aisha
    Ul Haq, Burhan
    Macha, Muzaffar A.
    Almilaibary, Abdullah
    Mir, Manzoor Ahmad
    HELIYON, 2024, 10 (03)
  • [39] New Results Will Change the Paradigm for Phase I Trials and Drug Approval
    Chabner, Bruce A.
    ONCOLOGIST, 2010, 15 (10) : 1023 - 1025
  • [40] Comparison of Oncology Drug Approval Between Health Canada and the US Food and Drug Administration
    Ezeife, Doreen A.
    Truong, Tony H.
    Heng, Daniel Y. C.
    Bourque, Sylvie
    Welch, Stephen A.
    Tang, Patricia A.
    CANCER, 2015, 121 (10) : 1688 - 1693
12345